Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
BMC Medical Research Methodology|December 13, 2023
The endorsement of general and artificial intelligence reporting guidelines in radiological journals: a meta-research studyJingyu Zhong, Yue Xing, Junjie Lu, et al.Translational Lung Cancer Research|April 23, 2021
High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterationsYiwei Liu, Wanying Wang, Fengying Wu, et al.Translational Lung Cancer Research|March 10, 2023
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutationsHaowei Wang, Lei Cheng, Chao Zhao, et al.Insights Into Imaging|July 17, 2025
Bone Reporting and Data System on MRI (Bone-RADS-MRI): a validation study by four readers on 275 cases from three local and two public databasesYue Xing, Yangfan Hu, Xianwei Liu, et al.Journal of Biomedical Science|March 17, 2025
Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4Zhangyuan Gu, Fugui Ye, Hong Luo, et al.Cancer Management and Research|May 27, 2021
Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung CancerXiaofei Yu, Zhengwei Dong, Wanying Wang, et al.Insights Into Imaging|August 12, 2025
Bone reporting and data system on CT (Bone-RADS-CT): a validation study by four readers on 328 cases from three local and two public databasesYue Xing, Defang Ding, Shun Dai, et al.Molecular Psychiatry|May 9, 2025
Implications of neurogenesis in depression through BDNF: rodent models, regulatory pathways, gut microbiota, and potential therapyHaijun Han, Jianhua Yao, Jinhan Wu, et al.Cancer Immunology, Immunotherapy : CII|June 7, 2021
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLCShiqi Mao, Fei Zhou, Yiwei Liu, et al.Experimental Hematology & Oncology|June 9, 2023
Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trialsShiqi Mao, Shuo Yang, Xinyu Liu, et al.Pageof 5